ArticleBreast cancer research : BCR2025

Retrospective review of metastatic hormone receptor-positive inflammatory breast cancer patients reveals poor responses to cyclin dependent kinase 4/6 inhibition.

Azadeh Nasrazadani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.